Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 57 entries
Sorted by: Best Match Show Resources per page
New approaches to risk stratification after myocardial infarction.

Journal of cardiovascular pharmacology

Breithardt G, Borggrefe M, Fetsch T, Budde T.
PMID: 1723125
J Cardiovasc Pharmacol. 1991;17:S82-6.

Parameters to assess the presence of electrical instability after myocardial infarction include spontaneous ventricular arrhythmias, late potentials, and programmed ventricular stimulation. The accuracy of the long-term electrocardiogram in correctly identifying high-risk patients has been questioned because spontaneous ventricular arrhythmias...

Cite
Breithardt G, Borggrefe M, Fetsch T, et al. New approaches to risk stratification after myocardial infarction. J Cardiovasc Pharmacol. 1991;17:S82-6
Breithardt, G., Borggrefe, M., Fetsch, T., & Budde, T. (1991). New approaches to risk stratification after myocardial infarction. Journal of cardiovascular pharmacology, 17S82-6.
Breithardt, G, et al. "New approaches to risk stratification after myocardial infarction." Journal of cardiovascular pharmacology vol. 17 (1991): S82-6.
Breithardt G, Borggrefe M, Fetsch T, Budde T. New approaches to risk stratification after myocardial infarction. J Cardiovasc Pharmacol. 1991;17:S82-6. PMID: 1723125.
Copy Download .nbib Format: NLM
Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis.

Arteriosclerosis, thrombosis, and vascular biology

Schuler-Luttmann S, Monnig G, Enbergs A, Schulte H, Breithardt G, Assmann G, Kerber S, von Eckardstein A.
PMID: 10764692
Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):E10-5.

Aging is associated with the progression of arteriosclerosis and the decline of several endocrine functions. We therefore investigated the association of coronary arteriosclerosis with hormones, the serum concentrations of which change during aging. Coronary angiograms of 189 men /=1...

Cite
Schuler-Luttmann S, Monnig G, Enbergs A, et al. Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis. Arterioscler Thromb Vasc Biol. 2000;20(4):E10-5
Schuler-Luttmann, S., Monnig, G., Enbergs, A., Schulte, H., Breithardt, G., Assmann, G., Kerber, S., & von Eckardstein A. (2000). Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis. Arteriosclerosis, thrombosis, and vascular biology, 20(4), E10-5.
Schuler-Luttmann, et al. "Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis." Arteriosclerosis, thrombosis, and vascular biology vol. 20,4 (2000): E10-5.
Schuler-Luttmann S, Monnig G, Enbergs A, Schulte H, Breithardt G, Assmann G, Kerber S, von Eckardstein A. Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis. Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):E10-5. PMID: 10764692.
Copy Download .nbib Format: NLM
X-ray magneto-optics in lanthanides.

Physical review letters

Starke K, Heigl F, Vollmer A, Weiss M, Reichardt G, Kaindl G.
PMID: 11327984
Phys Rev Lett. 2001 Apr 09;86(15):3415-8. doi: 10.1103/PhysRevLett.86.3415.

Magneto-optical methods in the visible light regime generally lack element specificity, which has become a considerable shortcoming in research on advanced heteromagnetic systems. Using circularly polarized soft x rays tuned to a 4d-4f core-level transition of a lanthanide element,...

Cite
Starke K, Heigl F, Vollmer A, et al. X-ray magneto-optics in lanthanides. Phys Rev Lett. 2001;86(15):3415-8doi: 10.1103/PhysRevLett.86.3415.
Starke, K., Heigl, F., Vollmer, A., Weiss, M., Reichardt, G., & Kaindl, G. (2001). X-ray magneto-optics in lanthanides. Physical review letters, 86(15), 3415-8. https://doi.org/10.1103/PhysRevLett.86.3415
Starke, K, et al. "X-ray magneto-optics in lanthanides." Physical review letters vol. 86,15 (2001): 3415-8. doi: https://doi.org/10.1103/PhysRevLett.86.3415
Starke K, Heigl F, Vollmer A, Weiss M, Reichardt G, Kaindl G. X-ray magneto-optics in lanthanides. Phys Rev Lett. 2001 Apr 09;86(15):3415-8. doi: 10.1103/PhysRevLett.86.3415. PMID: 11327984.
Copy Download .nbib Format: NLM
Analysis of factors influencing length of stay in the emergency department.

CJEM

Yoon P, Steiner I, Reinhardt G.
PMID: 17472779
CJEM. 2003 May;5(3):155-61. doi: 10.1017/s1481803500006539.

OBJECTIVES: Length of stay (LOS) is a key measure of emergency department (ED) throughput and a marker of overcrowding. Time studies that assess key ED processes will help clarify the causes of patient care delays and prolonged LOS. The...

Cite
Yoon P, Steiner I, Reinhardt G. Analysis of factors influencing length of stay in the emergency department. CJEM. 2003;5(3):155-61doi: 10.1017/s1481803500006539.
Yoon, P., Steiner, I., & Reinhardt, G. (2003). Analysis of factors influencing length of stay in the emergency department. CJEM, 5(3), 155-61. https://doi.org/10.1017/s1481803500006539
Yoon, Philip, et al. "Analysis of factors influencing length of stay in the emergency department." CJEM vol. 5,3 (2003): 155-61. doi: https://doi.org/10.1017/s1481803500006539
Yoon P, Steiner I, Reinhardt G. Analysis of factors influencing length of stay in the emergency department. CJEM. 2003 May;5(3):155-61. doi: 10.1017/s1481803500006539. PMID: 17472779.
Copy Download .nbib Format: NLM
Isolated non-compaction cardiomyopathy.

Deutsches Arzteblatt international

Engberding R, Stöllberger C, Ong P, Yelbuz TM, Gerecke BJ, Breithardt G.
PMID: 20386670
Dtsch Arztebl Int. 2010 Mar;107(12):206-13. doi: 10.3238/arztebl.2010.0206. Epub 2010 Mar 26.

BACKGROUND: Isolated non-compaction cardiomyopathy (NCCM) was first described in 1984. This disorder, a primary genetic cardiomyopathy, is now attracting increased attention.METHOD: The current state of the epidemiology, pathogenesis, pathophysiology, clinical features, diagnosis, treatment, and prognosis of NCCM are discussed...

Cite
Engberding R, Stöllberger C, Ong P, et al. Isolated non-compaction cardiomyopathy. Dtsch Arztebl Int. 2010;107(12):206-13doi: 10.3238/arztebl.2010.0206.
Engberding, R., Stöllberger, C., Ong, P., Yelbuz, T. M., Gerecke, B. J., & Breithardt, G. (2010). Isolated non-compaction cardiomyopathy. Deutsches Arzteblatt international, 107(12), 206-13. https://doi.org/10.3238/arztebl.2010.0206
Engberding, Rolf, et al. "Isolated non-compaction cardiomyopathy." Deutsches Arzteblatt international vol. 107,12 (2010): 206-13. doi: https://doi.org/10.3238/arztebl.2010.0206
Engberding R, Stöllberger C, Ong P, Yelbuz TM, Gerecke BJ, Breithardt G. Isolated non-compaction cardiomyopathy. Dtsch Arztebl Int. 2010 Mar;107(12):206-13. doi: 10.3238/arztebl.2010.0206. Epub 2010 Mar 26. PMID: 20386670; PMCID: PMC2853150.
Copy Download .nbib Format: NLM
The Role of Decreased Hip IR as a Cause of Low Back Pain in a Golfer: a Case Report.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery

Reinhardt G.
PMID: 24426881
HSS J. 2013 Oct;9(3):278-83. doi: 10.1007/s11420-013-9353-9. Epub 2013 Aug 24.

BACKGROUND: Among golf injuries, low back pain (LBP) is the most common compliant for both professional and amateur golfers. Hip rotational range of motion (ROM) might be related to LBP in those who repeatedly place specific activity rotational demands...

Cite
Reinhardt G. The Role of Decreased Hip IR as a Cause of Low Back Pain in a Golfer: a Case Report. HSS J. 2013;9(3):278-83doi: 10.1007/s11420-013-9353-9.
Reinhardt, G. (2013). The Role of Decreased Hip IR as a Cause of Low Back Pain in a Golfer: a Case Report. HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 9(3), 278-83. https://doi.org/10.1007/s11420-013-9353-9
Reinhardt, Gregory. "The Role of Decreased Hip IR as a Cause of Low Back Pain in a Golfer: a Case Report." HSS journal : the musculoskeletal journal of Hospital for Special Surgery vol. 9,3 (2013): 278-83. doi: https://doi.org/10.1007/s11420-013-9353-9
Reinhardt G. The Role of Decreased Hip IR as a Cause of Low Back Pain in a Golfer: a Case Report. HSS J. 2013 Oct;9(3):278-83. doi: 10.1007/s11420-013-9353-9. Epub 2013 Aug 24. PMID: 24426881; PMCID: PMC3772174.
Copy Download .nbib Format: NLM
Amiodarone and implantable cardioverter-defibrillators in congestive heart failure.

Zeitschrift fur Kardiologie

Böcker D, Block M, Haverkamp W, Breithardt G.
PMID: 27320309
Z Kardiol. 1999 Oct;88:S036-9. doi: 10.1007/s003920050586.

Sudden death accounts for a significant proportion of all death in patients with heart failure. Of currently available therapy, amiodarone and the implantable defibrillator (ICD) appear to have the greatest potential to reduce sudden death in heart failure. In...

Cite
Böcker D, Block M, Haverkamp W, et al. Amiodarone and implantable cardioverter-defibrillators in congestive heart failure. Z Kardiol. 1999;88:S036-9doi: 10.1007/s003920050586.
Böcker, D., Block, M., Haverkamp, W., & Breithardt, G. (1999). Amiodarone and implantable cardioverter-defibrillators in congestive heart failure. Zeitschrift fur Kardiologie, 88S036-9. https://doi.org/10.1007/s003920050586
Böcker, D, et al. "Amiodarone and implantable cardioverter-defibrillators in congestive heart failure." Zeitschrift fur Kardiologie vol. 88 (1999): S036-9. doi: https://doi.org/10.1007/s003920050586
Böcker D, Block M, Haverkamp W, Breithardt G. Amiodarone and implantable cardioverter-defibrillators in congestive heart failure. Z Kardiol. 1999 Oct;88:S036-9. doi: 10.1007/s003920050586. PMID: 27320309.
Copy Download .nbib Format: NLM
Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF.

Heart rhythm O2

Ugowe FE, Hellkamp AS, Wang A, Becker RC, Berkowitz SD, Breithardt G, Fox KAA, Halperin JL, Hankey GJ, Mahaffey KW, Nessel CC, Singer DE, Patel MR, Piccini JP.
PMID: 34337571
Heart Rhythm O2. 2021 Apr 20;2(3):215-222. doi: 10.1016/j.hroo.2021.04.001. eCollection 2021 Jun.

BACKGROUND: Insulin use may be a better predictor of stroke risk and morbidity and mortality than diabetes in patients with atrial fibrillation (AF).OBJECTIVES: Determine if the increased risk of stroke observed in patients with AF and diabetes is restricted...

Cite
Ugowe FE, Hellkamp AS, Wang A, et al. Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF. Heart Rhythm O2. 2021;2(3):215-222doi: 10.1016/j.hroo.2021.04.001.
Ugowe, F. E., Hellkamp, A. S., Wang, A., Becker, R. C., Berkowitz, S. D., Breithardt, G., Fox, K. A. A., Halperin, J. L., Hankey, G. J., Mahaffey, K. W., Nessel, C. C., Singer, D. E., Patel, M. R., Piccini, J. P. (2021). Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF. Heart rhythm O2, 2(3), 215-222. https://doi.org/10.1016/j.hroo.2021.04.001
Ugowe, Francis E, et al. "Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF." Heart rhythm O2 vol. 2,3 (2021): 215-222. doi: https://doi.org/10.1016/j.hroo.2021.04.001
Ugowe FE, Hellkamp AS, Wang A, Becker RC, Berkowitz SD, Breithardt G, Fox KAA, Halperin JL, Hankey GJ, Mahaffey KW, Nessel CC, Singer DE, Patel MR, Piccini JP. Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF. Heart Rhythm O2. 2021 Apr 20;2(3):215-222. doi: 10.1016/j.hroo.2021.04.001. eCollection 2021 Jun. PMID: 34337571; PMCID: PMC8322824.
Copy Download .nbib Format: NLM
Long-Term Effects of a Video-Based Smartphone App ("VIDEA Bewegt") to Increase the Physical Activity of German Adults: A Single-Armed Observational Follow-Up Study.

Nutrients

Reinhardt G, Timpel P, Schwarz PEH, Harst L.
PMID: 34959771
Nutrients. 2021 Nov 24;13(12). doi: 10.3390/nu13124215.

As physical inactivity is one of the four leading risk factors for mortality, it should be intensively treated. Therefore, this one-year follow-up study aimed to evaluate the long-term effects of a preventive app to increase physical activity in German...

Cite
Reinhardt G, Timpel P, Schwarz PEH, et al. Long-Term Effects of a Video-Based Smartphone App ("VIDEA Bewegt") to Increase the Physical Activity of German Adults: A Single-Armed Observational Follow-Up Study. Nutrients. 2021;13(12)doi: 10.3390/nu13124215.
Reinhardt, G., Timpel, P., Schwarz, P. E. H., & Harst, L. (2021). Long-Term Effects of a Video-Based Smartphone App ("VIDEA Bewegt") to Increase the Physical Activity of German Adults: A Single-Armed Observational Follow-Up Study. Nutrients, 13(12), . https://doi.org/10.3390/nu13124215
Reinhardt, Gesine, et al. "Long-Term Effects of a Video-Based Smartphone App ("VIDEA Bewegt") to Increase the Physical Activity of German Adults: A Single-Armed Observational Follow-Up Study." Nutrients vol. 13,12 (2021). doi: https://doi.org/10.3390/nu13124215
Reinhardt G, Timpel P, Schwarz PEH, Harst L. Long-Term Effects of a Video-Based Smartphone App ("VIDEA Bewegt") to Increase the Physical Activity of German Adults: A Single-Armed Observational Follow-Up Study. Nutrients. 2021 Nov 24;13(12). doi: 10.3390/nu13124215. PMID: 34959771.
Copy Download .nbib Format: NLM
The dawn of radiofrequency catheter ablation for cardiac arrhythmias.

Heart rhythm

Breithardt G, Borggrefe M.
PMID: 33648658
Heart Rhythm. 2021 Mar;18(3):485-486. doi: 10.1016/j.hrthm.2020.11.030.

No abstract available.

Cite
Breithardt G, Borggrefe M. The dawn of radiofrequency catheter ablation for cardiac arrhythmias. Heart Rhythm. 2021;18(3):485-486doi: 10.1016/j.hrthm.2020.11.030.
Breithardt, G., & Borggrefe, M. (2021). The dawn of radiofrequency catheter ablation for cardiac arrhythmias. Heart rhythm, 18(3), 485-486. https://doi.org/10.1016/j.hrthm.2020.11.030
Breithardt, Günter, and Borggrefe, Martin. "The dawn of radiofrequency catheter ablation for cardiac arrhythmias." Heart rhythm vol. 18,3 (2021): 485-486. doi: https://doi.org/10.1016/j.hrthm.2020.11.030
Breithardt G, Borggrefe M. The dawn of radiofrequency catheter ablation for cardiac arrhythmias. Heart Rhythm. 2021 Mar;18(3):485-486. doi: 10.1016/j.hrthm.2020.11.030. PMID: 33648658.
Copy Download .nbib Format: NLM
The ESC Ethics Committee.

European heart journal

Breithardt G.
PMID: 31327011
Eur Heart J. 2019 Jul 21;40(28):2284-2286. doi: 10.1093/eurheartj/ehz491.

No abstract available.

Cite
Breithardt G. The ESC Ethics Committee. Eur Heart J. 2019;40(28):2284-2286doi: 10.1093/eurheartj/ehz491.
Breithardt, G. (2019). The ESC Ethics Committee. European heart journal, 40(28), 2284-2286. https://doi.org/10.1093/eurheartj/ehz491
Breithardt, Günter. "The ESC Ethics Committee." European heart journal vol. 40,28 (2019): 2284-2286. doi: https://doi.org/10.1093/eurheartj/ehz491
Breithardt G. The ESC Ethics Committee. Eur Heart J. 2019 Jul 21;40(28):2284-2286. doi: 10.1093/eurheartj/ehz491. PMID: 31327011.
Copy Download .nbib Format: NLM
[Brugada syndrome. Current clinical aspects and risk stratification].

Herzschrittmachertherapie & Elektrophysiologie

Eckardt L, Rolf S, Mönnig G, Bruns HJ, Schulze-Bahr E, Milberg P, Kirchhof P, Wichter T, Borggrefe M, Breithardt G, Haverkamp W.
PMID: 24535450
Herzschrittmacherther Elektrophysiol. 2002 Sep;13(3):157-65. doi: 10.1007/s00399-002-0352-7.

Brugada syndrome (an electrocardiographic pattern of atypical right bundle branch block, ST-segment elevation in leads V1 to V3, and sudden cardiac death in the absence of structural heart disease) is at least in a subgroup of patients a genetically...

Cite
Eckardt L, Rolf S, Mönnig G, et al. Klinik und Therapie des Brugada-Syndroms. [Brugada syndrome. Current clinical aspects and risk stratification]. Herzschrittmacherther Elektrophysiol. 2002;13(3):157-65doi: 10.1007/s00399-002-0352-7.
Eckardt, L., Rolf, S., Mönnig, G., Bruns, H. J., Schulze-Bahr, E., Milberg, P., Kirchhof, P., Wichter, T., Borggrefe, M., Breithardt, G., & Haverkamp, W. (2002). Klinik und Therapie des Brugada-Syndroms. [Brugada syndrome. Current clinical aspects and risk stratification]. Herzschrittmachertherapie & Elektrophysiologie, 13(3), 157-65. https://doi.org/10.1007/s00399-002-0352-7
Eckardt, Lars, et al. "Klinik und Therapie des Brugada-Syndroms." [Brugada syndrome. Current clinical aspects and risk stratification]. Herzschrittmachertherapie & Elektrophysiologie vol. 13,3 (2002): 157-65. doi: https://doi.org/10.1007/s00399-002-0352-7
Eckardt L, Rolf S, Mönnig G, Bruns HJ, Schulze-Bahr E, Milberg P, Kirchhof P, Wichter T, Borggrefe M, Breithardt G, Haverkamp W. Klinik und Therapie des Brugada-Syndroms. [Brugada syndrome. Current clinical aspects and risk stratification]. Herzschrittmacherther Elektrophysiol. 2002 Sep;13(3):157-65. doi: 10.1007/s00399-002-0352-7. German. PMID: 24535450.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 57 entries